A new amyloidogenic transthyretin variant, [D38A], detected by electrospray ionization/mass spectrometry.
A new variant of transthyretin (TTR) was detected by mass spectrometry (MS) in a 63-year-old Japanese female patient suffering from amyloidosis. TTR was analyzed by 2-dimensional liquid chromatography coupled with electrospray ionization MS. Variant TTR showed extra peaks in addition to normal TTR peaks. The extra peaks were about 44 Da smaller than normal TTR peaks, and the abundance of variant peaks showed about 80% of the corresponding normal free and adduct peaks. Direct genomic DNA sequencing of TTR exon 2 showed both adenine and cytosine in the position corresponding to the second base of codon 38. This codes for a variant alanine (GCT) as well as the normal aspartic acid (GAT), indicating that the case is heterozygous for the substitution, [D38A].
Kishikawa
M
M
Department of Clinical Pathology, Osaka Medical College, Japan.
Nakanishi
T
T
Miyazaki
A
A
Shimizu
A
A
Kusaka
H
H
Fukui
M
M
Nishiue
T
T
D000682:Amyloid / Q000737:chemistry / Q000235:genetics*; D000686:Amyloidosis / Q000097:blood / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006579:Heterozygote; D006801:Humans; D007564:Japan; D013058:Mass Spectrometry; D008875:Middle Aged; D009154:Mutation; D016133:Polymerase Chain Reaction; D011228:Prealbumin / Q000737:chemistry / Q000235:genetics*; D017421:Sequence Analysis
D000682:Amyloid; D011228:Prealbumin